Anaerobic bacterial flora of intra-abdominal infections and their antimicrobial susceptibility pattern in Kuwait

被引:5
|
作者
Panigrahi, D [1 ]
Rotimi, VO [1 ]
Dhar, R [1 ]
Chugh, TD [1 ]
Dhar, PM [1 ]
Ghali, A [1 ]
Saad, A [1 ]
Sanyal, SC [1 ]
Varghese, TL [1 ]
机构
[1] Kuwait Univ, Fac Allied Hlth, Hlth Sci Ctr, Sulibikhat 90805, Kuwait
关键词
intra-abdominal infections; anaerobic bacteria; antibiotic susceptibility;
D O I
10.1006/anae.2001.0404
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Clinical samples obtained from 200 patients with intra-abdominal infections were investigated for the presence of anaerobic bacteria. The majority of samples were from patients with appendicitis (108, 54%) followed by peritoneal abscess/peritonitis (37, 18.5%). A total of 153 anaerobes were isolated from 83 culture positive specimens with an isolation rate of 1.8 per sample. Ninety (59%) yielded Bacteroides fragilis group and B. fragilis stricto sensu accounted for half of them. Other isolates were 36 (23.5%) Prevotella species and 15 (9.8%) Peptostreptococcus micros. The susceptibility of the 153 isolates against eight antibiotics was determined by the E-test. All the isolates were susceptible to metronidazole, MIC(90)s varying between 1-2 mug/mL. The Prevotella spp., Peptostreptococcus spp., Fusobacterium spp. and Porphyromonas spp. were all susceptible to clindamycin (MIC(90)s = 0.25-2 mug/mL respectively), imipenem (MIC(90)s = 0.12-0.5 mug/mL respectively) and meropenem (MIC90 = 0.25 mug/mL each). About 25% of the B. fragilis group were resistant to clindamycin with MIC more than 256 mug/mL. Piperacillintazobactam also exhibited excellent in vitro activity against all the isolates (MIC90 = 0.25 mug/mL). (C) 2001 Academic Press.
引用
收藏
页码:291 / 295
页数:5
相关论文
共 50 条
  • [1] Susceptibility of anaerobic flora recovered from complicated intra-abdominal infections to clinafloxacin and imipenem
    Hopkins, JA
    Wilson, SE
    Shimabukuro, J
    Chavez, C
    ANAEROBE, 1999, 5 (3-4) : 435 - 437
  • [2] Antimicrobial treatment for intra-abdominal infections
    Mazuski, John E.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (17) : 2933 - 2945
  • [3] Antimicrobial treatment of intra-abdominal infections
    Elsakr, R
    Johnson, DA
    Younes, Z
    Oldfield, EC
    DIGESTIVE DISEASES, 1998, 16 (01) : 47 - 60
  • [5] Anaerobic Coverage in Intra-Abdominal and Biliary Infections
    Maves, Ryan C.
    Halsey, Eric S.
    SURGICAL INFECTIONS, 2011, 12 (02) : 149 - 149
  • [6] INTRA-ABDOMINAL INFECTIONS DUE TO ANAEROBIC GERMS
    LECHAUX, JP
    GRECO, J
    GRETILLAT, F
    ACAR, JF
    REVUE DU PRATICIEN, 1977, 27 (03): : 135 - &
  • [7] Antimicrobial susceptibility of bacteria isolated from patients with intra-abdominal infections in China
    Cao, Xueyuan
    Jiang, Jing
    Ma, Lin
    Liu, Ru-Ming
    Wang, Quan
    Suo, Jian
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 60 - 60
  • [8] Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy
    Goldstein, EJC
    Snydman, DR
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 : 29 - 36
  • [9] Antimicrobial and antimycotic therapy of intra-abdominal infections
    Kujath, P.
    Hoffmann, M.
    Rodloff, A.
    CHIRURG, 2008, 79 (04): : 295 - +
  • [10] Duration of antimicrobial therapy for intra-abdominal infections
    Hedrick, TL
    Sawyer, RG
    INFECTIONS IN MEDICINE, 2004, 21 (10) : 506 - 510